JPMorgan International Research Enhanced Equity ETF
- ETF
- Ticker JIRE
- NYSE
Performance, volatility and drawdowns of JPMorgan International Research Enhanced Equity ETF since 06/2022, with distributions reinvested and calculated in US dollars. As of 20 Nov 2026.
Performance
$10,000 grew to $14,485. Global equities (VT): $15,235.
Distributions reinvested, before taxes and brokerage costs. Dashed: Global equities (VT) for comparison.
Declines from the peak
Lowest point −16.1% in 09/2022, measured from the peak in 08/2022. It took 4 months to get back to the old peak.
Factor profile
Monthly returns 07/2022 to 09/2026, measured against Developed markets ex US. The factors explain 97% of the variation.
- Market
- 0.99
- Size
- −0.38
- Value
- 0.08
- Profitability
- 0.30
- Low investment
- 0.01
- Momentum
- 0.01
How to read this: JIRE moves about as much as the stock market (Developed markets ex US). The ETF leans towards large companies and profitable companies.
A value of 1 for the market means: when the market rises by 1%, the ETF rises by 1% on average. The other values show the lean towards small, cheaply valued, profitable, conservatively investing and recently strong stocks; bold where it is clear. Calculated with the Fama and French factors and momentum.
Annual returns
Best year 2025 at +31.8%, weakest 2024 at +3.1%. 3 of 3 full years were positive. * partial year.
Similar ETFs
Frequently asked questions
How has JIRE performed since 06/2022?
$10,000 grew to $17,510 by 20 Nov 2026, which is +13.5% per year. Distributions are reinvested; taxes and brokerage costs are not deducted.
How volatile is JIRE?
Volatility was 15.4% per year, measured on monthly returns. The largest decline from a peak was −16.1%, with the low in 09/2022.
How does JIRE compare with a broad equity ETF?
Over the same period Global equities (VT) returned +14.4% per year at 14.7% volatility, JIRE returned +13.5% at 15.4%. The correlation of monthly returns was 0.89; 1 would mean they moved in lockstep.
What does JIRE hold?
JIRE holds 202 positions. The largest are ASML Holding NV, Siemens AG (Registered) and AstraZeneca plc; the 10 largest together make up 16.9% of the fund (holdings as of 31 Jul 2026, according to the fund's filing with the SEC).
Which currency are the figures in?
In US dollars, the currency of the US listing.